Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZILRETTA in Glenohumeral Osteoarthritis
NCT06269705Phase 3Active, not recruiting
- Sponsor
- Pacira BioSciences
- Start
- Feb 2024
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide in glenohumeral osteoarthritis, sponsored by Pacira BioSciences. Started Feb 2024; status: active, not recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
glenohumeral osteoarthritis
Beyond the preview
Go deeper on NCT06269705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06269705.